1. Home
  2. LASR vs NNNN Comparison

LASR vs NNNN Comparison

Compare LASR & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • NNNN
  • Stock Information
  • Founded
  • LASR 2000
  • NNNN 2021
  • Country
  • LASR United States
  • NNNN Germany
  • Employees
  • LASR N/A
  • NNNN N/A
  • Industry
  • LASR Semiconductors
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • LASR Technology
  • NNNN Health Care
  • Exchange
  • LASR Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • LASR 412.8M
  • NNNN 369.6M
  • IPO Year
  • LASR 2018
  • NNNN 2025
  • Fundamental
  • Price
  • LASR $17.40
  • NNNN $16.10
  • Analyst Decision
  • LASR Strong Buy
  • NNNN
  • Analyst Count
  • LASR 4
  • NNNN 0
  • Target Price
  • LASR $16.13
  • NNNN N/A
  • AVG Volume (30 Days)
  • LASR 981.7K
  • NNNN 78.0K
  • Earning Date
  • LASR 07-31-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • LASR N/A
  • NNNN N/A
  • EPS Growth
  • LASR N/A
  • NNNN N/A
  • EPS
  • LASR N/A
  • NNNN 0.06
  • Revenue
  • LASR $205,689,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • LASR $13.20
  • NNNN N/A
  • Revenue Next Year
  • LASR $8.66
  • NNNN N/A
  • P/E Ratio
  • LASR N/A
  • NNNN $286.95
  • Revenue Growth
  • LASR 2.66
  • NNNN 21.95
  • 52 Week Low
  • LASR $6.20
  • NNNN $5.18
  • 52 Week High
  • LASR $19.44
  • NNNN $18.50
  • Technical
  • Relative Strength Index (RSI)
  • LASR 62.88
  • NNNN N/A
  • Support Level
  • LASR $17.45
  • NNNN N/A
  • Resistance Level
  • LASR $19.44
  • NNNN N/A
  • Average True Range (ATR)
  • LASR 0.92
  • NNNN 0.00
  • MACD
  • LASR -0.17
  • NNNN 0.00
  • Stochastic Oscillator
  • LASR 53.59
  • NNNN 0.00

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: